How big is the Muscle Atrophy Market | Size, Share & Growth Forecast 2026

Q: What is the projected size of the muscle atrophy market by 2031?

The muscle atrophy market is expected to reach USD 13.7 billion by 2031.

Q: What is the projected CAGR of the muscle atrophy market?

The muscle atrophy market is expected to grow at a CAGR of 10.20% during 2025-2031.

Q: What factors are driving the growth of the muscle atrophy market?

The growth is driven by rising cases of sarcopenia, increasing incidences of neuromuscular disorders, and growing demand for rehabilitation therapies.

Q: Who are the major players in the muscle atrophy market?

Key players include Pfizer Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, and Cytokinetics, Inc.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA7075

Publication Date: Jul 2025

What is the size of Muscle Atrophy Market?

According to 6Wresearch internal database and industry insights, the muscle atrophy market was valued at USD 7.8 Billion in 2025 and is anticipated to reach USD 13.7 Billion by 2032, growing at a CAGR of 10.20% during the forecast period (2026–2032).

This growth is driven by increasing prevalence of chronic diseases, aging populations, and the rising incidence of prolonged immobility due to surgeries or injuries. Moreover, advancements in regenerative medicine, physiotherapy solutions, and targeted drug therapies are fueling market expansion.

Growth Factors of the Muscle Atrophy Market

Rising incidence of neuromuscular disorders and orthopedic injuries.
Growing geriatric population susceptible to muscle degeneration.
Increasing awareness and availability of physiotherapy and rehabilitation programs.
Development of advanced biologics and anti-inflammatory drugs.
Growing demand for home-based and telehealth rehabilitation solutions.
Technological innovations in electrical stimulation devices and robotic rehabilitation systems.

Muscle Atrophy Market Trends

Muscle Atrophy Market is evolving with increasing adoption of regenerative therapies like stem cell treatments and biologics. Wearable rehabilitation devices and AI-driven physiotherapy programs are gaining popularity for at-home recovery.

Moreover, telemedicine platforms integrated with remote monitoring and muscle activity trackers are becoming standard in treatment plans. Pharmaceutical companies are also investing in novel therapies targeting muscle preservation and recovery acceleration.

Emerging Developments in the Muscle Atrophy Market

In the Muscle Atrophy Market, emerging developments include AI-assisted rehabilitation programs, 3D-printed orthotics, and innovative combination therapies involving biologics and physical rehabilitation. Gene therapy and CRISPR-based research are also under focus to address hereditary muscle atrophy disorders. Partnerships between pharma companies and digital health platforms are driving personalized therapy solutions.